Fungal infection in surgical patients

American Journal of Surgery
D A Dean, K W Burchard

Abstract

Invasive fungal infections have become a major source of morbidity and mortality in the modern surgical intensive care unit. Patients at risk for invasion and dissemination are common, and are not as ill as thought previously. Severity of illness (APACHE II score > 10, ventilator use for >48 hours), antibiotics, central venous lines, total parenteral nutrition, burns, and immunosuppression are the most common risk factors. Recognition of these risk factors should arouse a high index of suspicion for the diagnosis of invasion or dissemination. Unfortunately, laboratory tests alone lack sensitivity and specificity. Therefore, the diagnosis of invasion and dissemination in the majority of cases requires the acquisition and proper interpretation of clinical evidence. Once the diagnosis is made, early systemic treatment is warranted. Reported toxicity and efficacy supports the use of fluconazole for most patients with invasive fungal infections. However, for the most critically ill patients amphotericin B remains the treatment of choice.

References

Oct 1, 1979·Annals of Internal Medicine·J R WingardR Saral
Dec 1, 1977·Archives of Internal Medicine·J F PlouffeF R Fekety
Sep 1, 1979·The Journal of Infectious Diseases·P C CravenH B Skrdlant
Apr 1, 1978·Archives of Internal Medicine·C I JarowskiR T Silver
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G P Bodey
Aug 11, 1992·Infection and Immunity·J E EdwardsR A Calderone
Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V J FraserW C Dunagan
Jan 1, 1992·The Journal of Surgical Research·J A AlverdyD A Burke
Mar 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E Edwards, S G Filler
Jan 1, 1991·JPEN. Journal of Parenteral and Enteral Nutrition·P J HennesseyR J Andrassy
Jan 1, 1990·The American Journal of Clinical Nutrition·C A GogosN C Zoumbos
Mar 1, 1990·Reviews of Infectious Diseases·K W BrammerJ K Faulkner
Jan 1, 1990·Journal of Clinical Microbiology·R J SherertzL L Fauerbach
Sep 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I CabezudoC P Burns
Nov 1, 1989·Reviews of Infectious Diseases·R D Diamond
Jan 1, 1989·Pancreas·J M Howard, V M Bieluch
Oct 1, 1989·Archives of Internal Medicine·S B WeyR P Wenzel
Oct 1, 1989·The Pediatric Infectious Disease Journal·R W Byard
Dec 1, 1988·Archives of Internal Medicine·S B WeyR P Wenzel
Jan 1, 1987·Critical Reviews in Microbiology·H Vanden BosscheP Marichal
Feb 1, 1987·Archives of Surgery·G J Slotman, K W Burchard
Mar 1, 1985·Archives of Surgery·D L DyessD E Fry
Sep 1, 1985·Reviews of Infectious Diseases·R HornD Armstrong
May 1, 1974·Annals of Surgery·H H StoneJ Z Cuzzell
Sep 9, 1974·JAMA : the Journal of the American Medical Association·G P Bodey, M Luna
Aug 1, 1974·The American Journal of Medicine·C A Kauffman, J S Tan
Jun 1, 1966·The American Journal of Medicine·M S Seelig
Jan 1, 1968·Digestion·G Volkheimer, F H Schulz
Jul 1, 1980·The Journal of Antimicrobial Chemotherapy·J W Van Der MeerJ Brugmans
Nov 1, 1983·American Journal of Clinical Pathology·W F HickeyF J Schoen
Oct 1, 1984·Human Pathology·J B AtkinsonR Virmani

❮ Previous
Next ❯

Citations

Jan 31, 1998·The Surgical Clinics of North America·M S Farber, J H Abrams
Jan 9, 2001·Diagnostic Microbiology and Infectious Disease·J LoefflerH Einsele
Feb 24, 2001·Mycoses·J BernhardtH Bernhardt
Oct 9, 2009·Surgical Infections·Ludwik K BranskiDavid N Herndon
May 7, 2002·Critical Care Medicine·Per SandvenUNKNOWN NORGAS Group and the Norwegian Yeast Study Group
Feb 18, 2009·Journal of Gastroenterology and Hepatology·Rakesh KochharKartar Singh
Feb 9, 2011·Journal of Gastroenterology and Hepatology·Rakesh KochharJaidev Wig
Dec 8, 2004·Journal of Clinical Microbiology·Alexandra CorreiaCélia Pais
Oct 1, 2004·Drugs·Stijn Blot, Koenraad Vandewoude
Feb 26, 2010·World Journal of Biological Chemistry·André Luis Souza Dos Santos
Nov 20, 2012·Burns : Journal of the International Society for Burn Injuries·Ayelet Raz-PasteurDana Egozi
Aug 12, 2008·Burns : Journal of the International Society for Burn Injuries·Clinton K MurraySteven E Wolf
Jun 19, 2007·The Journal of Hospital Infection·S P ToyaG E Tzelepis
Dec 14, 2011·Mycoses·Gabriele Sganga
Apr 30, 1998·The Journal of Hospital Infection·P G Flanagan, R A Barnes
Nov 20, 2013·Journal de mycologie médicale·M J NajafzadehG S de Hoog
Jul 25, 2015·Journal of Photochemistry and Photobiology. B, Biology·Krzysztof TutajRafal Luchowski
Apr 14, 2005·Mycoses·C BoosH-P Bruch
Feb 21, 2006·FEMS Immunology and Medical Microbiology·André Luis Souza dos SantosRosangela Maria de Araújo Soares
Jul 11, 2016·Revista iberoamericana de micología·Ana Isabel RenauMiguel Salavert
Aug 25, 2004·Clinics in Laboratory Medicine·Gary W Procop, Glenn D Roberts
Mar 26, 2011·Journal of Applied Oral Science : Revista FOB·Patrícia Monteiro RibeiroAntonio Olavo Cardoso Jorge
May 15, 2004·The Journal of Hospital Infection·A M TortoranoM A Viviani
Feb 11, 2011·The Journal of Trauma·Ana Filipa Bastos Pedrosa, Acácio Gonçalves Rodrigues
Dec 8, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·S P GoldbergW L Holman
Aug 6, 2014·African Journal of Laboratory Medicine·Rita O OladeleMalcolm Richardson
Mar 8, 2007·Annals of Saudi Medicine·I Al-Mohsen, W T Hughes
Nov 26, 2009·Cirugía española·Xavier GuiraoCésar García Rey
Dec 7, 2010·Enfermedades infecciosas y microbiología clínica·Xavier Guirao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.